Cargando…

Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma

This study aimed to construct immune-related predictors to identify responders to anti-PD1 therapy of melanoma through CIBERSORT algorithm. Using the least absolute shrinkage and selection operator (LASSO) logistic regression, we constructed an immunoscore consisting of 8 immune subsets to predict t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Run-Cong, Yuan, Shu-Qiang, Wang, Yun, Chen, Ying-Bo, Cai, Yan-Yu, Chen, Shi, Li, Shu-Man, Zhou, Jie, Chen, Guo-Ming, Luo, Tian-Qi, Zhou, Zhi-Wei, Li, Yuan-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932919/ https://www.ncbi.nlm.nih.gov/pubmed/31796647 http://dx.doi.org/10.18632/aging.102556

Ejemplares similares

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma
por: Nie, Run-Cong, et al.
Publicado: (2020)

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2021)

Recent Findings in the Posttranslational Modifications of PD-L1
por: Li, Shu-Man, et al.
Publicado: (2020)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2020)

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials
por: Zhao, Bai-Wei, et al.
Publicado: (2022)

Immunoscore: a new possible approach for melanoma classification
por: Capone, Mariaelena, et al.
Publicado: (2014)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis
por: Chen, Xiao-Jiang, et al.
Publicado: (2020)

An immunoscore nomogram for predicting survival in patients with oesophageal cancer
por: Li, Gaoming, et al.
Publicado: (2021)

Prognostic Value of the Nutritional Risk Screening 2002 Scale in Metastatic Gastric Cancer: A Large-Scale Cohort Study
por: Li, Yuan-Fang, et al.
Publicado: (2019)

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
por: Bifulco, Carlo, et al.
Publicado: (2014)

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
por: Galon, J., et al.
Publicado: (2016)

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
por: Li, Yanyan, et al.
Publicado: (2020)

Bursectomy for advanced gastric cancer: an update meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2018)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2019)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology
por: Zeng, Liang, et al.
Publicado: (2022)

Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2017)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
por: Nie, Run-Cong, et al.
Publicado: (2020)

Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers
por: Kim, Kyung-Ju, et al.
Publicado: (2017)

Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection
por: Zhu, Bao-Yan, et al.
Publicado: (2019)

Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data
por: Nie, Run-Cong, et al.
Publicado: (2021)

Gene expression profiles for a prognostic immunoscore in gastric cancer
por: Zeng, D., et al.
Publicado: (2018)

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
por: Galon, Jérôme, et al.
Publicado: (2014)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis
por: Yuan, Shu-Qiang, et al.
Publicado: (2017)

A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis
por: Chen, Xiao-Jiang, et al.
Publicado: (2023)

Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors
por: Zhang, You-Cheng, et al.
Publicado: (2023)

Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy
por: Zhou, Jie, et al.
Publicado: (2022)

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
por: Wang, Fulong, et al.
Publicado: (2023)

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
por: Wu, Zi-You, et al.
Publicado: (2020)

Endoscopic ultrasonography compared with multidetector computed tomography for the preoperative staging of gastric cancer: a meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2017)

Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation
por: Liu, Ruiqi, et al.
Publicado: (2018)

Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy
por: Zhou, Yu, et al.
Publicado: (2017)

Biomarkers immune monitoring technology primer: Immunoscore® Colon
por: Hermitte, Fabienne
Publicado: (2016)

Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
por: Wirta, Erkki‐Ville, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ifagr68av6jp2mp056178a2qt5